The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Webcast
In this short webcast, Dena Jackson, vice president, Clinical Supply Chain, Providence St.
Webcast
In this short webcast, Dena Jackson and Sophie Rutherford discuss connecting the organization to the supply chain department to build collabor
Case Studies
AHRMM is building a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Supply Chain Strategies & Solutions Article
By: Nicholas Link
Download Article
Supply Chain Strategies & Solutions Article
Outcomes-based contracting is no easy feat but when conducted properly, it creates a synergistic model that can significantly improve outcomes.
Supply Chain Strategies & Solutions Article
By: Antony Koblish